Consolidated Condensed Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
Cash flows from operating activities:
Net income	$ 269,399	$ 267,020
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	189,362	186,387
Asset Impairment Charges	0	28,372
Stock-based compensation expense	18,517	16,127
Deferred income taxes, net	69,063	50,027
Other Noncash Expense	580
Other non-cash expense (income), net		(8,605)
Changes in assets and liabilities:
Trade receivables, net	(99,727)	172,735
Inventories, net	30,680	(3,160)
Accounts payable and accrued liabilities	86,278	(85,346)
Deferred revenue	(22,434)	(132,366)
Income taxes payable - excess tax benefit from share award exercises	(2,423)	(2,837)
Income taxes payable - other	(3,073)	(18,580)
Other assets and liabilities, net	14,915	(2,795)
Net cash provided by operating activities	551,137	466,979
Cash flows from investing activities:
Capital expenditures	(85,595)	(145,772)
Acquisition of businesses, net of cash acquired	0	(327,555)
Other investing activities, net	10,579	6,849
Net cash used in investing activities	(75,016)	(466,478)
Cash flows from financing activities:
Proceeds from borrowings under Vail Holdings Credit Agreement	0	892,625
Proceeds from borrowings under Whistler Credit Agreement	21,144	202,304
Proceeds from Convertible Debt	575,000	0
Repayments of borrowings under Vail Holdings Credit Agreement	(46,875)	(396,250)
Repayments of borrowings under Whistler Credit Agreement	(44,050)	(39,044)
Employee taxes paid for share award exercises	(9,265)	(10,071)
Dividends paid	0	(212,734)
Repurchases of common stock	0	(46,422)
Other financing activities, net	(21,638)	(19,034)
Net cash provided by financing activities	474,316	371,374
Effect of exchange rate changes on cash, cash equivalents and restricted cash	3,863	2,851
Net increase in cash, cash equivalents and restricted cash	954,300	374,726
Cash, cash equivalents and restricted cash:
Beginning of period	402,086	118,389
End of period	1,356,386	493,115
Accrued capital expenditures	$ 7,299	$ 11,727